High Potent OSD expertise
Specialist experience supporting potent compounds from early development through first-in-human supply.
Prepare for Phase I
A smarter path to first-in-human (FIH) is vital, and one of the most significant transitions in drug development.
The decisions you make around formulation, manufacturability, packaging, and clinical supply can influence not only your Phase I study, but also how efficiently your program progresses beyond it.
Reduce complexity & risk.
Through our integrated development, manufacturing, packaging, and clinical supply planning, we help your program prepare for Phase I by reducing complexity and minimizing risk to support a smoother transition.
It starts earlier than you think...
Successfully reaching first-in-human isn't just about completing preclinical activities; it's about making smarter decisions early to support efficient manufacturing, reliable clinical supply, and program progression. Our early-phase specialists will plan with you to reduce unnecessary handoffs, avoid delays and create a stronger foundation for the next stage of development.
Build. Plan. Align.
We streamline regulatory submission processes to support timely product registrations and approvals across global markets. Our teams navigate complex regional requirements to help ensure compliance, reduce risk, and keep launch timelines on track.
Shape formulation and manufacturability decisions early so Phase I supply is practical, scalable and aligned with future development plans.
Support first-human-dose strategies with contained HP-OSD approaches that consider limited API availability, dose sensitivity and evolving clinical requirements.
Early planning matters.
Taking a connected approach from the outset reduces downstream risk and creates a smoother route into first-in-human studies. Combining specialist HP-OSD expertise with integrated development, manufacturing, packaging and clinical supply capabilities, we help programs move confidently from preclinical development into first-in-human studies.
Today’s Pre-Clinical Phase. Inspired by tomorrow.
Integrated CDMO support
Development, manufacturing, packaging and clinical supply connected through one integrated partner.
Built for phase progression
Early decisions made with future scale, supply and development requirements already in mind.
Connect with a PCI early-phase specialist today to discuss preparing your HP-OSD program for a successful, smarter transition.